CONMED CORP - NOTE 2.625% 2/0

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Debt / NOTE 2.625% 2/0
Market price (% of par)
109.68%
Total 13F principal
$67,256,000
Principal change
+$702,000
Total reported market value
$73,852,000
Number of holders
33
Value change
-$380,484
Number of buys
15
Number of sells
13

Institutional Holders of CONMED CORP - NOTE 2.625% 2/0 as of Q3 2022

As of 30 Sep 2022, CONMED CORP - NOTE 2.625% 2/0 was held by 33 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $67,256,000 in principal (par value) of the bond. The largest 10 bondholders included CAPSTONE INVESTMENT ADVISORS, LLC, WOLVERINE ASSET MANAGEMENT LLC, MACKAY SHIELDS LLC, WELLS FARGO & COMPANY/MN, JPMORGAN CHASE & CO, WESTWOOD HOLDINGS GROUP INC, ABSOLUTE INVESTMENT ADVISERS LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, SHENKMAN CAPITAL MANAGEMENT INC, and GABELLI FUNDS LLC. This page lists 33 institutional bondholders reporting positions for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.